Stock overview
Nuvalent Inc.
Explore the company, reported ownership, price history, and available source evidence.
Historical Nuvalent Class A common stock, traded as NUVL. GSK acquired the company for $124.00 cash per share on July 15, 2026. Trading halted after the July 14 close and did not resume.
- Last close
- $123.96
- · NUVL
- Tracked holders
- 2 funds
- Latest available 13F per fund
NUVL · USD
Price
$123.96
Change unavailable
Close · Jul 14, 2026
Market closed
1 stored daily close
$123.96
Jul 14, 2026
- Range low
- $123.97
- Range high
- $123.97
- Observations
- 1
- Session date
- Jul 14, 2026
Jul 14, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | +216% 26'Q2 | $34,691,150 | 0.05% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +4866% 26'Q2 | $25,449,398 | 0.04% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market